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Receptor-linked protein-tyrosine phosphatases (RPTPs) are essential regulators of axon guidance and
synaptogenesis in Drosophila, but the signaling pathways in which they function are poorly defined. We
identified the cell surface receptor Tartan (Trn) as a candidate substrate for the neuronal RPTP Ptp52F by
using a modified two-hybrid screen with a substrate-trapping mutant of Ptp52F as “bait.” Trn can bind to the
Ptp52F substrate-trapping mutant in transfected Drosophila S2 cells if v-Src kinase, which phosphorylates Trn,
is also expressed. Coexpression of wild-type Ptp52F causes dephosphorylation of v-Src-phosphorylated Trn. To
examine the specificity of the interaction in vitro, we incubated Ptp52F–glutathione S-transferase (GST) fusion
proteins with pervanadate-treated S2 cell lysates. Wild-type Ptp52F dephosphorylated Trn, as well as most
other bands in the lysate. GST “pulldown” experiments demonstrated that the Ptp52F substrate-trapping
mutant binds exclusively to phospho-Trn. Wild-type Ptp52F pulled down dephosphorylated Trn, suggesting
that it forms a stable Ptp52F-Trn complex that persists after substrate dephosphorylation. To evaluate whether
Trn and Ptp52F are part of the same pathway in vivo, we examined motor axon guidance in mutant embryos.
trn and Ptp52F mutations produce identical phenotypes affecting the SNa motor nerve. The genes also display
dosage-dependent interactions, suggesting that Ptp52F regulates Trn signaling in SNa motor neurons.
Receptor-linked protein-tyrosine phosphatases (RPTPs) are
enzymes with extracellular (XC) domains, a single transmem-
brane domain, and one or two cytoplasmic protein tyrosine
phosphatase (PTP) homology domains. Many RPTPs have XC
sequences that resemble those of cell adhesion molecules (for
a review, see reference 33). This sequence organization sug-
gests that RPTPs can couple cell-cell recognition events to
dephosphorylation of cytoplasmic substrates. Interestingly,
while phosphotyrosine (PY) pathways involved in cell growth
and differentiation typically involve receptor tyrosine kinases
that bind to growth factors and are regulated by nontransmem-
brane PTPs, those that control axon guidance often use RPTPs
and nontransmembrane TKs. This implies that the cues that
affect PY signaling in axonal growth cones may interact with
RPTPs rather than with receptor tyrosine kinases (reviewed in
reference 14).
There are 17 active RPTPs encoded in the human genome,
while Drosophila has six. Most of the mammalian RPTPs are
expressed in nonneural tissues, but four of the six fly RPTPs
are expressed only by central nervous system (CNS) neurons in
late embryos. All published zygotic phenotypes produced by
Rptp mutations are alterations in axon guidance or synapto-
genesis. These results suggest that the major functions of the
Drosophila RPTPs are in neural development (for a review, see
reference 16). Analysis of axon guidance phenotypes in em-
bryos bearing single or multiple Rptp mutations is consistent
with the idea that RPTP interactions with ligands at growth
cone choice points convey “information,” in the form of
changes in substrate phosphorylation within growth cones, that
is used to determine pathway decisions.
In the Drosophila neuromuscular system, 36 motor axons
grow out within six nerve bundles in each abdominal hemiseg-
ment, and each axonal growth cone makes a series of geneti-
cally determined guidance decisions that direct it to the appro-
priate muscle fiber (for a review, see reference 27). Our work
on Rptp mutant combinations suggests that each pathway de-
cision uses a specific subset of the six RPTPs. RPTPs can
exhibit functional redundancy, so that the loss of one does not
produce a defect unless another RPTP is also absent, or com-
petition, in which loss of one RPTP suppresses the phenotype
produced by loss of another (5, 6, 31). Examination of RPTP
expression patterns suggests that the RPTPs are expressed by
most (or possibly all) CNS neurons, including motor neurons.
If so, the requirements for individual RPTPs for execution of
particular guidance decisions cannot be due to selective ex-
pression of these RPTPs on specific motor axons. These re-
quirements might instead be determined by the expression
patterns of RPTP ligands, so that only RPTPs whose ligands
were localized to the vicinity of a growth cone choice point
would participate in that pathway decision. Alternatively (or in
addition), the necessity of a particular RPTP for a pathway
decision might arise from selective expression of RPTP sub-
strates, so that an RPTP would be important for guidance
decisions made by a growth cone of a specific motor neuron
only if that neuron expressed the relevant substrate(s).
Evaluation of such models requires identification of specific
XC ligands and intracellular substrates for the Drosophila
RPTPs. Only one set of ligands has been identified thus far.
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These are the heparan sulfate proteoglycans Syndecan (Sdc)
and Dallylike (Dlp), which bind to the Lar RPTP with nano-
molar affinity and contribute to its functions in axon guidance
and synapse growth (9, 15). Similarly, little is known about
substrate specificity in vivo. Lar can dephosphorylate the En-
abled (Ena) protein, which regulates the growth cone cy-
toskeleton, and genetic interaction studies suggest that Ena
may be an in vivo substrate for Lar (35). The transmem-
brane protein gp150 can be dephosphorylated by Ptp10D in
cell culture and intact fly larvae, but genetics has not pro-
vided evidence that Ptp10D and gp150 are in the same
signaling pathway in vivo (7).
The identification of in vivo substrates for RPTPs has been
hampered by the fact that purified RPTP cytoplasmic domains
often do not exhibit high selectivity in vitro when tested for
dephosphorylation activity on peptides or proteins. The most
fruitful method for finding substrates for both RPTPs and
cytoplasmic PTPs has been the use of “substrate-trapping”
mutants. The most effective substrate traps were devised by
Tonks and coworkers, and are created by changing an invariant
Asp (D) residue within the PTP active site to Ala (A) (8). The
D residue has an abnormal pK and is thus able to donate a
proton to the phosphorus-oxygen bond, facilitating displace-
ment of the tyrosine (Y) OH by the invariant Cys (C) nucleo-
phile of the enzyme. This creates a phosphoenzyme interme-
diate. The dephosphorylated substrate then dissociates, and
water attacks the Cys-phosphate bond, releasing the phosphate
and reconstituting the enzyme. In D3A mutants, the polar-
ization of the phosphorus-oxygen bond by protonation cannot
take place, and the PY substrate remains bound to the enzyme.
Substrate-trapping mutants expressed in cells often bind to
only a few phosphoproteins, suggesting that PTPs exhibit high
specificity in vivo (see, for example, reference 11).
We conducted a modified yeast two-hybrid screen to find
Drosophila phosphoproteins that bind selectively to RPTP sub-
strate-trapping mutants. We identified the cell surface receptor
Tartan (Trn) in this screen and showed that it is a substrate for
the Ptp52F RPTP in Drosophila Schneider 2 (S2) cells. Axon
guidance phenotypes in trn mutants are identical to those seen
in Ptp52F mutants, and trn and Ptp52F exhibit dosage-depen-
dent genetic interactions. These results suggest that Ptp52F is
a regulator of Trn signaling in motor neurons in vivo.
MATERIALS AND METHODS
Yeast two-hybrid screening. The cytoplasmic domains of the RPTPs were
cloned in frame into a GAL4:DBD vector, pGBDUC2, a gift from Philip James;
this bears the URA3 selectable marker. We made point mutations to change the
invariant D to an A in these vectors. For Ptp52F, this is D1258 (numbered in the
context of the entire 1,433-amino-acid [aa] preprotein). The activated c-Src
construct in BTM116 (bearing a TRP1 marker) was a gift from Kathy Keegan.
The library was a 0 to 24 h. cDNA library made in theACT (LEU2) vector and
was a gift from Stephen Elledge. The insert size range is 0.5 to 6 kb, with an
average insert size of 1.8 kb. The strains used for selection are described in
reference 13 and were a gift from P. James. Yeast cells were transformed by
using standard lithium acetate protocols. For the screen, “bait” cells, bearing the
substrate-trap PTP vector and the c-Src vector, and “prey” cells, bearing the
library, were grown up in selection medium, and equal numbers of bait and prey
cells were mixed for mating and grown up for a few hours. The mated cells were
plated ontoAde plates and incubated at 30°C for 7 days. Positive colonies were
patched onto Ade plates and then tested for activation of the HIS3 and LacZ
reporters. Colonies that activated all of the reporters were tested for bait de-
pendence by using 5-fluoroorotic acid to remove the URA3 bait plasmid. They
were tested for kinase dependence by replica plating onto Trp and Trp
plates, followed by examination of whether the colonies lacking the c-Src vector
were still ADE. Bait-dependent plasmids were sequenced and then retrans-
formed into yeast, together with each substrate trap or wild-type PTP bait, with
or without c-Src (see Table 1 for results).
Plasmid construction. We subcloned the Ptp52F cytoplasmic domain into a
modified version of the metallothionein (MT) promoter vector pRMHa3 (2) that
includes an ATG and Src myristylation sequence, followed by restriction sites.
We added a 9xMyc, His8 tag from the HTM53H plasmid (a gift from Ray
Deshaies) to the C terminus. This produced the wild-type 52F plasmid used in
Fig. 3. We introduced the D1258A mutation into this plasmid, generating the
substrate-trapping mutant used in Fig. 3. The full-length untagged Trn cDNA
sequence in the POT2 vector (GH10871 cDNA clone) was subcloned into
pRMHa3 to produce the Trn-FL plasmid used in Fig. 3. The Trn-cyto-green
fluorescent protein (GFP) plasmid used in Fig. 2 and 4 was made by subcloning
the entire cytoplasmic domain of Trn into a derivative of pRMHa3 that con-
tained both the myristylation sequence and the GFP sequence, flanking the
cloning sites. The Trn-FL-GFP plasmid used in Fig. 3 was made by replacing the
cytoplasmic domain of Trn in the Trn-FL plasmid with a cytoplasmic domain-
GFP fused sequence from the Trn-cyto-GFP plasmid. The D-Src64B and D-Abl
plasmids are described in reference 7 and were originally obtained from Alan
Comer. The v-Src plasmid used in Fig. 2 and 3 was made by cloning the entire
coding region of v-Src (from Tony Hunter) into the pRMHa3 vector. Details
concerning cloning strategies (enzyme sites, primers, etc.) are available on re-
quest.
S2 cell transfection. S2 cells were maintained in Schneider’s medium supple-
mented with 100 U of penicillin-streptomycin/ml, 2.5 g of amphotericin B/ml,
and 10% heat-inactivated fetal bovine serum. Cells were grown at 25°C under
standard conditions and were transiently transfected by calcium phosphate-
mediated DNA transfer. Briefly, 3  106 cells per 60-mm plate were seeded in
serum-only medium and expanded overnight till the cells reached 2  106 to 4 
106 cells/ml. The cells were then transfected for 15 to 18 h by the addition of 600
TABLE 1. Summary of the modified yeast two-hybrid screen for RPTP substrates
Probe (kinase plus bait) Gene Type of protein No. of clonesfound Additional interacting probe(s)
a
src  10D Xmas-2 RNA binding 1 src  52F
CG12533 Calponin homology (actin binding) 9 10D
src  52F trn LRR cell surface receptor 1 None
CG15022 Proline rich 1 None
CG10283 No defined domains 1 None
src  69D CG9418 DNA binding, HMG box 4 69D
src  99A csp Cysteine string protein (synaptic) 1 99A, 10D, src 10D
CG11110 Leader peptidase 1 99A
a That is, additional probe(s) with which the protein specified in columns 2 and 3 interacts.
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l of DNA-calcium phosphate coprecipitate mix (which included 3 g of each
plasmid DNA). For the findings shown in Fig. 3, experiments that examined the
association of Trn with the Ptp52F trap, we cotransfected 3 g each of Ptp52F-
trap-Myc, the v-Src plasmid, and the Trn-FL, Trn cyto-GFP, or Trn FL-GFP
plasmid. For the experiment to examine dephosphorylation of Trn FL-GFP by
Ptp52F, the Ptp52F–wild-type–Myc plasmid was substituted for the trap plasmid.
CuSO4 (500 M final concentration) was added to the cells for 48 h prior to
harvesting to induce expression from the MT promoter.
S2 transfection data for the other three candidate substrates. We have not yet
examined Xmas-2, which may be an RNA-binding protein, because the se-
quences of the proteins encoded by the Xmas genes are not well defined and
full-length cDNA clones are not available. The clone identified in the yeast
screen corresponds to part of Xmas-2. However, the Xmas-1 gene immediately
downstream might be a part of the same functional unit, and published results do
not clearly delineate the respective roles of these two coding sequences.
CG15022 and CG10283 have no conserved domains, and they are not homolo-
gous to other proteins in nondrosophilid species. We obtained full-length cDNA
clones for CG15022 and CG10283, attached their coding regions to N-terminal
FLAG epitope tags, and cloned the tagged versions into MT promoter vectors.
We transiently transfected these plasmids into S2 cells and induced expression
from the MT promoter with copper. We observed that we could detect single
bands on immunoblots of cell lysates that corresponded to the expected sizes of
the tagged proteins, and both proteins were phosphorylated in pervanadate-
treated cells. However, for CG15022, we discovered that phosphorylation was
likely to be on the FLAG tag, which contains a Y, because a CG15022-GFP
fusion was not phosphorylated under the same conditions. This may be of
interest to other investigators who are examining the phosphorylation of FLAG-
tagged proteins. We have not yet examined a CG10283-GFP fusion to determine
whether CG10283-FLAG phosphorylation is also due to the FLAG tag.
Cell lysis and immunoprecipitation. Cells were washed with cold phosphate-
buffered saline (PBS) and lysed in ice-cold lysis buffer (125 mM NaCl, 100 mM
Tris-Cl [pH 7.4], 0.2% Triton X-100, 1 mM EDTA, 600 mM phenylmethylsul-
fonyl fluoride, 1 g of protease inhibitor cocktail/ml, 10% glycerol). Lysates were
clarified by centrifugation at 35,000  g for 20 min and subjected to immuno-
precipitation (200-l volume) using either 4 l of a mouse anti-GFP antibody
(Roche), 15 l of a mouse anti-Myc antibody supernatant (9E10), or 1 l of a
rabbit anti-Trn antibody (a gift from Allen Laughon). Immune complexes were
isolated by binding to protein G plus protein A-agarose beads (Oncogene Sci-
ence, Inc.), followed by two cycles of lysis buffer washes. The washed immuno-
precipitates were boiled in sodium dodecyl sulfate sample buffer, resolved on
polyacrylamide gels, and transferred to polyvinylidene difluoride membranes.
For Western blotting, we used a BM Chemiluminescence kit (Roche, catalog no.
1520709). Anti-Myc (9E10) supernatant (a gift from the Deshaies lab) was used
at a 1:15 dilution for blotting, while anti-Trn, anti-GFP (Roche), and anti-PY
(monoclonal antibody [MAb] 4G10; Millipore) were used at a 1:1,000 dilution.
GST fusion proteins, pulldowns, and enzymatic assays. The Ptp52F-trap–
glutathione S-transferase (GST) and Ptp52F–wild-type–GST fusion protein plas-
mids were created by PCR amplification of the Ptp52F cytoplasmic domain from
the Ptp52F-Myc vectors described above. The Myc and His tags were included in
the PCR product, but the myristylation sequence was not. The PCR products
were subcloned in frame into the pGEX-2T vector to produce N-terminal GST
fusions. These plasmids were transformed into the BL21 strain, and protein
expression in liquid culture was induced with 50 M IPTG (isopropyl--D-
thiogalactopyranoside) at 30°C for 4 h. Fusion proteins, which bear the His8 tag,
were purified by using Qiagen Ni-NTA Superflow resin according to the manu-
facturer’s instructions. For enzymatic and pulldown assays, S2 cells (transfected
or untransfected) were treated with pervanadate (2 mM Na3VO4, 3 mM H2O2)
for 30 min at 25°C. Cells were washed with PBS and lysed in ice-cold lysis buffer
with 5 mM iodoacetic acid. These lysates were incubated for 30 min with shaking
in the cold, and then dithiothreitol was added to a final concentration of 10 mM.
Lysates were centrifuged at high speed for 20 min in the cold. For dephosphor-
ylation experiments such as those in Fig. 4A, lysate was mixed with various
amounts of purified Ptp52F-wild type-GST and incubated for 1 h at 20°C. To
assay dephosphorylation of Trn-cyto-GFP (Fig. 4B), lysate from transfected cells
was first immunoprecipitated with mouse anti-GFP, and then Ptp52F-wild type-
GST was added to the immunoprecipitate (IP) beads, and the mixture was
incubated with rotation under the same conditions as for the lysate. For the GST
pulldown experiment of Fig. 4C, the Ptp52F-trap-GST fusion protein was bound
to glutathione-agarose beads for 2 h in the cold; pervanadate-treated lysate was
then added, and the mixture was incubated with rotation overnight in the cold,
after which the beads were spun down. The beads were washed with PBS and
boiled in sodium dodecyl sulfate sample buffer. In some experiments, Ptp52F-
trap-GST was incubated with lysate for 1 h at 20°C, after which glutathione-
agarose beads were added, and the mixture was incubated with rotation over-
night in the cold. This worked equally well. Samples from dephosphorylation and
pulldown experiments were subjected to electrophoresis on polyacrylamide gels
and analyzed by Western blotting with anti-PY or anti-Trn as described above.
Genetic analysis. We combined the trn28.4 allele with the Ptp52F18.3 allele,
crossing these stocks (over GFP balancers) to generate Ptp52F18.3/, trn28.4/
embryos. trn28.4 is a P element excision mutation that deletes coding sequence
and is likely to be a null mutation. Our group has also examined other trn alleles.
For example, Kurusu et al. (22) presented penetrance data for trns064117, which
is a hypomorph; it generates the same phenotypes as trn28.4, but with a reduced
penetrance. Ptp52F18.3 is a missense mutation that we defined as a possible null
because it has the same phenotypic strength over itself or over a deficiency
mutation (29). Two other Ptp52F alleles, Ptp52F7.8.1 and Ptp52F8.10.3, were also
found (29) to produce the same phenotypes as Ptp52F18.3 but with a lower
penetrance. In one experiment (see Fig. S1 in the supplemental material), a line
with an “EP” (UAS-containing) P element upstream of the Ptp52F gene (ob-
tained from Florenci Serras) was crossed to the Elav-GAL4 “driver line,” in
backgrounds with or without the trn28.4 mutation. Thus, to remove trn function,
both the driver and the EP lines were made heterozygous for the trn mutation
over a GFP balancer, and embryos were sorted to find those which were
EP52F  Elav-GAL4, trn/trn. Midline crossovers were scored in 1D4-stained
embryos, and these data are shown in the bar graph in Fig. S1 in the supple-
mental material. Staining of fixed whole-mount embryos was done as described
previously (25). Staining of live-dissected embryos was performed as described by
Fox and Zinn (9). Two primary antibodies were used: mouse anti-FasII MAb
1D4 (Developmental Studies Hybridoma Bank), diluted 1:5, and rabbit anti-Trn
(3), diluted 1:400. Cy3-conjugated or horseradish peroxidase (HRP)-conjugated
secondary antibodies (Jackson Immunoresearch, West Grove, PA) were used at
dilutions of 1:400 (Cy3) or 1:200 (HRP). Whole-mount embryos, stained using
HRP immunohistochemistry, were dissected, and embryo “fillets” were photo-
graphed by using differential interference contrast optics on a Zeiss Axioplan
microscope with a Magnafire camera. For quantitation of phenotypes, we scored
segments A2 to A6, which have identical SNa morphologies.
RESULTS
Identification of candidate RPTP substrates using a modi-
fied yeast two-hybrid screen. To search for substrates for the
Drosophila RPTPs, we used methods similar to those devised
by Keegan and Cooper (18) and by Noda and coworkers (10,
17). We cloned cytoplasmic domain sequences from four
RPTPs into a yeast two-hybrid expression vector, inserting
them in frame with the LexA DNA-binding domain (DBD).
The four RPTPs are Ptp10D, Ptp52F, Ptp69D, and Ptp99A.
We introduced substrate-trapping (D3A) mutations into each
of these RPTP sequences. Ptp10D and Ptp52F have only one
PTP homology domain, while Ptp69D and Ptp99A have two.
However, the second PTP homology domain in Ptp99A has a
D in place of the essential C residue, so it is unlikely to have
enzymatic activity. For Ptp69D, it is unknown whether the
second PTP homology domain is active, so we made a con-
struct with D3A mutations in both domains.
To perform the screen, we introduced a plasmid encoding a
version of chicken c-Src bearing three activating mutations
(18), together with the RPTP-DBD plasmids and a cDNA-
activation domain (AD) fusion library, and selected for ADE
yeast bearing all three types of plasmids (13). (Constitutive
expression of v-Src, which has additional activating mutations,
is not tolerated well by yeast, while this version of c-Src can be
expressed without adversely affecting growth.)
To screen these candidates, we first tested them for HIS
and LacZ, the other two selectable markers in the strain (13).
We removed the URA3 (RPTP-DBD) “bait” plasmid and
discarded candidates that were still ADE in the absence of
the bait. The bait-dependent clones we obtained are listed in
Table 1. For each of these, we determined whether the ADE
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phenotype required c-Src expression. Four clones that passed
this test were identified, each encoding a different protein.
Three were identified by screening with Ptp52F/c-Src, and one
was identified by screening with Ptp10D/c-Src.
Each of these putative substrate clones was then reintro-
duced into yeast, together with each RPTP bait plasmid, with
or without the c-Src plasmid. We also tested the four classes of
non-Src-dependent clones in the same manner. Table 1 shows
that the three clones identified with Ptp52F/c-Src are ADE
only with this bait, while the Xmas-2 clone identified with
Ptp10D/Src also interacts with Ptp52F/c-Src. Figure 1 shows
plates with streaked yeast colonies harboring one Ptp52F/c-
Src-selected clone encoding a fragment of Trn. Yeast express-
ing Trn-AD grew on plates lacking Ade only when they also
contained the Ptp52F-trap-DBD and c-Src plasmids.
Finally, we examined whether selection of these four puta-
tive Ptp52F substrate clones requires the substrate-trapping
mutation by transforming them into yeast together with c-Src
and a plasmid encoding the wild-type Ptp52F cytoplasmic do-
main fused to the DBD. None of the clones generated the
ADE phenotype with wild-type Ptp52F. In summary, these
data show that four Drosophila sequences, encoding portions
of the Trn, Xmas-2, CG15022, and CG10283 proteins, selec-
tively interact with the substrate-trapping mutant version of
the RPTP in the presence of c-Src and therefore behave like
substrates in this yeast assay.
Phosphorylation of Trn in cultured Drosophila cells. We
then wanted to determine whether the candidates identified in
the yeast screen could exhibit phosphorylation-dependent in-
teractions with RPTP substrate-trapping mutants in trans-
fected Drosophila S2 cells. Such a demonstration would pro-
vide a rigorous test of whether interactions between the
candidate substrates and the substrate-trapping mutant can
occur when both proteins are present within cells from the
species of origin. In a recent review of PTP-substrate interac-
tions, substrate-trapping within cotransfected cells is defined as
the most selective criterion for establishing that a candidate
protein is a bona fide substrate (32).
We present here the S2 transfection results for Trn. The
data for the other three candidates are in Materials and Meth-
ods. Trn is a cell surface protein with an XC domain composed
primarily of leucine-rich repeats, which are 24-aa motifs that
mediate protein-protein interactions. The Trn preprotein is
737 aa in length, and its cytoplasmic domain is 274 aa and
contains 11 Y residues. The Trn coding fragment identified in
the modified two-hybrid screen corresponds to cytoplasmic
domain sequence from 38 aa located C-terminal to the trans-
membrane domain through to the stop codon.
Trn is normally expressed in S2 cells. Thus, in order to study
phosphorylation of exogenous Trn and distinguish it from en-
dogenous Trn, we needed to express “tagged” versions of trun-
cated or full-length Trn by transfection. We initially expressed
a fusion protein consisting of the myristylation sequence from
Src, the complete cytoplasmic domain of Trn, and the com-
plete GFP coding region. Myristylation of the protein should
promote its association with the plasma membrane. We trans-
fected MT promoter plasmids encoding this protein, Trn-cyto-
GFP, into S2 cells and induced expression with copper. Ty-
rosine phosphorylation was induced by treating the transfected
cells with H2O2 and Na3VO4 (pervanadate), which causes mas-
sive accumulation of PY in intact cells by inhibiting all PTP
activity, for 30 min prior to lysis. This treatment efficiently
induced phosphorylation of endogenous Trn (data not shown).
We examined lysates and anti-GFP IPs from these cells by
immunoblotting with anti-GFP and anti-PY. A single band of
60 kDa was seen, a finding consistent with the predicted
molecular mass of Trn-cyto-GFP (Fig. 2A, lanes 1 and 2).
Immunoblotting of lysates from pervanadate-treated cells
with anti-PY produced an intense signal at all molecular mass
positions (Fig. 2B, lane 3). Pervanadate treatment of S2 cells
generates so many phosphoprotein bands that they cannot be
resolved on a gel, while discrete bands can sometimes be ob-
served in lysates of pervanadate-treated mammalian cells (see,
for example, reference 11). In anti-GFP IPs of these lysates,
the 60-kDa Trn-cyto-GFP band (Fig. 2A, lane 2) disappeared
and was replaced by two or three bands (Fig. 2A, lane 4) that
migrated more slowly. These bands are likely to represent
tyrosine-phosphorylated Trn-cyto-GFP species, since they
were also detected by immunoblotting with anti-PY (Fig. 2B,
lane 4, labeled as P-Trn).
We also attempted to induce Trn phosphorylation by ex-
pressing two Drosophila TKs, D-Src64B and D-Abl. We had
previously shown that the TK expression plasmids we used for
cotransfection can both increase phosphorylation of Ena in S2
cells, demonstrating that the kinases are functional (7). How-
ever, neither kinase was able to cause tyrosine phosphorylation
of Trn-cyto-GFP (Fig. 2B, lanes 6 and 8), and the intensity of
the tyrosine-phosphorylated bands seen in lysates was not
greatly increased in cells expressing these kinases (Fig. 2B,
compare lane 1 to lanes 5 and 7). Since neither of these Dro-
sophila TKs could induce Trn phosphorylation, we next tested
chicken v-Src, which is a highly active TK. Transfection of a
v-Src expression plasmid produced more tyrosine phosphory-
lation in lysates than the D-Src or D-Abl plasmids (compare
Fig. 2B, lanes 5 and 7, to Fig. 2C, lane 2). Trn-cyto-GFP was
phosphorylated in cells expressing v-Src, although at lower
levels than those attained with pervanadate treatment (Fig. 2C,
lanes 3 and 4, P-Trn band).
Phosphorylated Trn binds to the Ptp52F substrate-trapping
mutant in S2 cells. Having demonstrated that the Trn cyto-
FIG. 1. Selection of Trn in the yeast screen: growth onAde plates
depends on both Ptp52F and c-Src. The left plate has streaks of yeast
colonies (five independent colonies for each) transformed with
Trn-AD (LEU), with or without Ptp52F-trap-DBD or Ptp99A-trap-
DBD, with or without c-Src, as indicated. All of these grew on plates
lacking leucine (LEU). The right plate has streaks of the same yeast
colonies on plates lacking adenine (ADE). Only the yeast with
Ptp52F-trap-DBD and c-Src could express the ADE2 gene and grow
on these plates.
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plasmic domain can be phosphorylated in S2 cells, we con-
ducted cotransfection experiments to determine whether the
Ptp52F substrate-trapping mutant could bind to v-Src-phos-
phorylated Trn. This experiment cannot be done in pervana-
date-treated cells, because vanadate binds to the active sites of
trap mutants and blocks their association with substrates.
Ptp52F is not endogenously expressed in S2 cells, so inter-
actions between Trn and Ptp52F can only be studied in cells
transfected with Ptp52F constructs. The predicted Ptp52F pre-
protein is 1,433 aa in length, and its cytoplasmic domain is 369
aa. Full-length Ptp52F cDNAs have never been isolated, and
we had to use reverse transcription-PCR to define the com-
plete sequence of its XC domain (29). Because of this, we
decided to express the Ptp52F cytoplasmic domain with a myri-
stylation sequence in S2 cells, so that it would be likely to
associate with the plasma membrane and might therefore
come into contact with Trn. We made wild-type and substrate-
trapping mutant constructs with N-terminal Src myristylation
sequences and 9xMyc tags at the C terminus. When these were
transfected into S2 cells, a single band of 65 kDa was ob-
served in lysates and anti-Myc IPs, which is consistent with the
predicted molecular mass of the fusion protein (Fig. 3A).
Because we had demonstrated that Trn-cyto-GFP could be
phosphorylated in S2 cells, we cotransfected Ptp52F-trap-Myc,
Trn-cyto-GFP, and v-Src constructs in our initial experiments
but did not find any evidence for association. This could have
been due to inefficient localization of the Ptp52F and Trn
proteins to the same compartment, to occlusion of trap binding
to the cytoplasmic domain by GFP, or to insufficiently high
expression of one of the proteins. To address these issues, we
then made a construct (Trn-FL) with untagged full-length Trn.
When transfected into S2 cells, this resulted in expression of
wild-type Trn protein (85 kDa) at levels severalfold greater
than those seen for endogenous Trn in untransfected cells
(data not shown). When we cotransfected Ptp52F-trap-Myc
and Trn-FL constructs into S2 cells together with v-Src, we
were able to detect Trn in Myc IPs from these cells (Fig. 3B,
lane 2). This Trn band was much weaker in Myc IPs from
Ptp52F-wild type-Myc-cotransfected cells (Fig. 3B, lane 5). It
can be clearly visualized upon longer exposure, however, show-
ing that Ptp52F-wild type-Myc can also form a complex with
Trn, albeit with a lower efficiency than the substrate-trapping
mutant.
To further examine association between Ptp52F and Trn, we
needed to make a tagged Trn fusion protein that could bind to
the Ptp52F substrate-trap, so that we could distinguish this
protein from endogenous Trn. We thus made a construct in
which GFP was attached to the C terminus of full-length Trn.
When a plasmid bearing this construct, Trn-FL-GFP, was
transfected, we observed a band of 100 kDa that could be
precipitated by either anti-GFP or anti-Trn antibodies (Fig.
3C). Interestingly, we also saw a second band of 60 kDa that
reacted with both antibodies. This appears to be a cleavage
product, and given its size and the fact that it must contain
GFP, we infer that the XC domain can be cleaved near the
plasma membrane.
To study dephosphorylation of Trn-FL-GFP, we cotrans-
fected it together with Ptp52F-wild type-Myc or Ptp52F-trap-
FIG. 2. Tartan is tyrosine phosphorylated in v-Src-transfected S2 cells. (A) Anti-GFP immunoblot of lysates (L) and anti-GFP IPs (I) from cells
transfected with the Trn cyto-GFP plasmid. As indicated by “” and “” signs above the blot, cells were left untreated (lanes 1 and 2), treated
with pervanadate (lanes 3 and 4), or cotransfected with D-Abl (lanes 5 and 6) or D-Src64B plasmids (lanes 7 and 8). The immunoglobulin G heavy
chain (IgG HC), unphosphorylated Trn-cyto-GFP, and tyrosine-phosphorylated Trn-cyto-GFP bands (P-Trn) are labeled. (B) Anti-PY immuno-
blot of the same samples. The IgG HC and P-Trn bands are labeled. (C) Anti-PY immunoblot of lysates and anti-GFP IPs from cells transfected
with the Trn cyto-GFP plasmid. Cells were left untreated (lane 1), cotransfected with the v-Src plasmid (lanes 2 and 3), or treated with pervanadate
(lane 4). The IgG HC and P-Trn bands are labeled. Note that the P-Trn band in lane 3 migrates more rapidly than that in lane 4, suggesting that
Trn is less heavily tyrosine phosphorylated in v-Src-expressing cells than in pervanadate-treated cells.
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Myc and v-Src. Trn-FL-GFP and the cleavage product were
both tyrosine phosphorylated when cotransfected with the
Ptp52F trap and Src (Fig. 3D, lane 1). This was not due to
protection from endogenous PTP activity by trap binding, be-
cause phosphorylation was detected at the same levels when
Trn-FL-GFP and v-Src were cotransfected without the trap
(data not shown). This is consistent with the observation that
only a small fraction of Trn is bound by the trap (Fig. 3B).
When wild-type Ptp52F was expressed together with Trn-FL-
GFP and the kinase, tyrosine-phosphorylated Trn and its
cleavage product were barely detectable (Fig. 3D, lane 2).
These data show that Ptp52F can cause dephosphorylation of
the Trn cytoplasmic domain.
To examine whether Ptp52F-trap-Myc could bind to Trn-
FL-GFP, we immunoprecipitated the Trn protein with anti-
GFP and then detected the Ptp52F protein by immunoblotting
with anti-Myc. We observed a clear signal when Ptp52F-trap-
Myc was cotransfected with both v-Src and Trn-FL-GFP (Fig.
3E, lane 5), but no association was detected when the kinase
construct was omitted. These data show that the substrate-
trapping mutant binds to Trn in a phosphorylation-dependent
manner. With wild-type Ptp52F, a very faint band was observed
in Myc immunoblots of anti-GFP IPs (Fig. 3E, lane 11), indi-
cating that there was much less association between the wild-
type RPTP and Trn. This band is clearly visible with longer
exposure, however, demonstrating that the wild-type RPTP
does form a complex with Trn-FL-GFP in cotransfected cells.
When lysates were immunoprecipitated with anti-Myc, we
were able to observe the association of Trn-FL-GFP with
Ptp52F-trap-Myc by immunoblotting with anti-PY (Fig. 3F,
FIG. 3. Phosphorylated Trn binds to the Ptp52F substrate-trapping mutant and is dephosphorylated by wild-type Ptp52F in S2 cells. (A) An
anti-Myc immunoblot of lysates (L), anti-Myc IPs (I), and post-IP supernatants (P) from cells that were cotransfected with the Trn-FL and v-Src
plasmids. As indicated by “” and “” signs above the blot, these cells were also transfected with the Ptp52F-trap-Myc plasmid (lanes 1 to 3) or
the Ptp52F–wild-type–Myc plasmid (lanes 4 to 6). The region of the blot containing the 65-kDa Ptp52F-Myc band is shown. (B) Anti-Trn
immunoblot of the same samples. Note that a strong Trn band was present in anti-Myc IPs of cells cotransfected with Ptp52F-trap-Myc (lane 2),
but only a very faint signal was seen when Ptp52F-wild type-Myc was cotransfected (lane 5). This shows that the substrate-trapping mutant bound
selectively to Trn-FL. (C) Anti-GFP immunoblot of lysate (L), an anti-GFP IP, and an anti-Trn IP from cells transfected with the Trn-FL-GFP
plasmid. An 100-kDa band was present (labeled as Trn FL-GFP), as expected. An 60-kDa band that is likely to represent a cleavage product
was also present (labeled as cleaved Trn-GFP). The cleavage site must be in the XC domain, close to the membrane, based on the size of this
product. The IgG heavy chain (IgG HC) band is also labeled. (D) Anti-PY blot of anti-GFP IPs from S2 cells cotransfected with the Trn FL-GFP
and v-Src plasmids, together with either the Ptp52F-trap-Myc (lane 1) or Ptp52F-wild type-Myc (lane 2) plasmids. Note that both the Trn-FL-GFP
and cleaved Trn-GFP bands were tyrosine phosphorylated in lane 1; similar levels of phosphorylation were observed when the trap was not
cotransfected. When Ptp52F-wild type-Myc was cotransfected, the PY signal was barely detectable for Trn-FL-GFP and undetectable for the
cleaved product. This shows that Ptp52F caused dephosphorylation of v-Src-phosphorylated Trn-FL-GFP and the cleavage product. (E) Anti-Myc
immunoblot of lysates (L), anti-GFP IPs (GI), and anti-Myc IPs (MI) from cells transfected with Trn-FL-GFP. Cells were also transfected with
Ptp52F-trap-Myc (lanes 1 to 6) or Ptp52F-wild type-Myc (lanes 7 to 12) plasmids, with (lanes 4 to 6 and lanes 10 to 12) or without (lanes 1 to 3
and lanes 7 to 9) the v-Src plasmid. The region of the blot containing the 65-kDa Ptp52F-Myc band is shown. Note that this band was detected
in anti-GFP IPs from cells cotransfected with Ptp52F-trap-Myc and v-Src (lane 5) but was not detectable in anti-GFP IPs from trap-transfected
cells lacking the kinase (lane 2). A very faint signal was observed in anti-GFP IPs from cells transfected with Ptp52F-wild type-Myc and the kinase
(lane 11). This shows that the substrate-trapping mutant bound to Trn-FL-GFP in a phosphorylation-dependent manner. (F) Anti-PY immunoblot
of the same anti-GFP (GI) or anti-Myc (MI) IPs. Note that, as in panel D, the phosphorylated Trn-FL-GFP and cleavage product bands were
present when Ptp52F-trap-Myc and v-Src were both transfected (lane 3) but were absent when Ptp52F-wild type-Myc and v-Src were transfected
(lane 7). Faint signals were present for both the Trn-FL-GFP and cleavage product bands in lane 4, which is an anti-Myc IP from cells transfected
with Ptp52F-trap-Myc and v-Src; this confirms that phosphorylated Trn-FL-GFP associated with the trap. The IgG HC band is also labeled.
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lane 4), although the signal was always weaker than that seen
when anti-GFP IPs were probed with anti-Myc. Figure 3B, lane
2, shows that we can readily detect Trn-FL by blotting anti-Myc
IPs with anti-Trn. However, for reasons we do not understand,
we could not reproducibly detect association between Trn-
FL-GFP and Ptp52F-trap-Myc by blotting anti-Myc IPs with
anti-GFP.
Selective in vitro binding of Ptp52F and Trn. The results
described above demonstrate that the Ptp52F substrate-trap-
ping mutant can bind to Trn in S2 cells and that wild-type
Ptp52F can cause dephosphorylation of Trn. However, these
data do not show that Trn is the only protein in S2 cells that
binds to the Ptp52F trap. To address selectivity, it is necessary
to examine binding to the entire spectrum of proteins that are
tyrosine phosphorylated when cells are treated with pervana-
date. This cannot be done by cotransfection, since vanadate
occludes binding by PTP substrate-trapping mutants.
Many other investigators (see, for example, reference 11)
have performed experiments in which they assessed binding of
PTP substrate-trapping mutants purified as GST fusion pro-
teins from Escherichia coli to proteins in a lysate from cells that
were treated with pervanadate, followed by inactivation of the
pervanadate with iodoacetate and dithiothreitol. We used this
approach for Ptp52F, purifying substrate-trapping mutant and
wild-type GST fusion proteins from E. coli lysates.
We first examined dephosphorylation by the wild-type
Ptp52F fusion protein. To do this, we added various amounts
of Ptp52F-wild type-GST to pervanadate-treated S2 cell ly-
sates, followed by incubation for 1 h at 20°C before fraction-
ating the samples on a gel and immunoblotting them with
anti-PY. Figure 4A shows that all of the bands in the lysate
were reduced in intensity as the amount of Ptp52F-wild type-
GST was increased. It is not obvious that any bands were
selectively dephosphorylated, although some bands appeared
to be more resistant than others. The PTP-GST fusion protein
appears to have a surprisingly low level of enzymatic activity,
since 1 g (150 nM) was required to achieve 75% dephos-
phorylation of most bands. However, other investigators have
obtained similar results: for example, 70 nM GST-SHP1 was
required to produce 75% dephosphorylation of the SHP-1
substrate Lck in vitro (4).
We also examined the dephosphorylation of Trn-cyto-GFP
by analyzing anti-GFP IPs from pervanadate-treated lysates of
cells transfected with the Trn-cyto-GFP plasmid. These data
(Fig. 4B) show that phosphorylation of the Trn-cyto-GFP pro-
tein was eliminated by 1 g of Ptp52F-GST fusion protein.
This experiment suggests that the wild-type enzyme does not
exhibit strong specificity for Trn-cyto-GFP as a substrate in
vitro, since many bands in Fig. 4A were also reduced in inten-
sity when 1 g of Ptp52F-GST was used. In other experiments,
we observed that 50% dephosphorylation of Trn-cyto-GFP
can be achieved with 100 ng of Ptp52F-wild type-GST (15
nM). This amount of Ptp52F-wild type-GST produces no de-
tectable effect when the entire lysate is analyzed. However,
since there are so many PY bands in a pervanadate-treated S2
cell lysate that individual bands cannot be resolved (e.g., lane
1 of Fig. 4A, and lanes 1 and 4 of Fig. 4D), we would not be
able to detect 50% dephosphorylation of other proteins (data
not shown).
To address the selectivity of Ptp52F trap binding, we incu-
bated various amounts of Ptp52F-trap-GST with pervanadate-
treated S2 cell lysates and precipitated protein bound to the
trap using glutathione-agarose beads. We then analyzed bead-
bound proteins by blotting with anti-PY as in Fig. 4A. This
produced a remarkable result: only a single prominent phos-
phoprotein band, of 85 kDa, was precipitated by the sub-
strate-trapping mutant (Fig. 4C). The migration of this band
was consistent with that of endogenous Trn, and it was recog-
nized by anti-Trn antibody (Fig. 4E, lane 1).
Although the cells used for the experiment of Fig. 4C were
transfected with Trn-cyto-GFP plasmid, no band correspond-
ing to Trn-cyto-GFP was detectable on the blot. We also could
not detect Trn-cyto-GFP or Trn-FL-GFP binding to Ptp52F-
trap-GST when glutathione-agarose precipitates were ana-
lyzed by immunoblotting with anti-GFP. Perhaps the GFP and
GST domains of the fusion proteins sterically interfere with
each other to prevent binding.
To further evaluate the interaction between Ptp52F-GST
and Trn, we then incubated 10 g of Ptp52F-trap-GST or
Ptp52F-wild type-GST with pervanadate-treated lysates from
cells transfected with untagged Trn-FL plasmids (or left un-
transfected) and detected bound phosphoproteins by blotting
the cells with anti-PY. Lysates from these cells are shown in
lanes 1 and 4 of Fig. 4D. As in Fig. 4C, we observed that
Ptp52F-trap-GST precipitated only a single 85-kDa band
from the lysates and that the intensity of this band was in-
creased when the cells had been transfected with Trn-FL, a
finding consistent with the identification of this band as phos-
pho-Trn (Fig. 4D, lanes 2 and 5).
When Ptp52F-wild type-GST was used for the pulldown, no
band was detected on the anti-PY blot. Interestingly, however,
when pulldowns from Trn-FL-transfected cells were blotted
with anti-Trn, equal amounts of Trn were observed to be pre-
cipitated by the wild-type and substrate-trapping mutant pro-
teins (Fig. 4E). These data show that the wild-type Ptp52F
protein can also form a stable complex with Trn that persists
after dephosphorylation. The stability of this complex, or the
affinity of Trn and Ptp52F for each other, may be lower for the
wild-type than for the substrate-trapping mutant, since much
more Trn associated with the substrate-trapping mutant in
cotransfected S2 cells (Fig. 3B, lane 2 versus lane 5; Fig. 3E,
lane 5 versus lane 11). However, the vast excess of wild-type
Ptp52F used in pulldown experiments is apparently capable of
bringing down the same amount of Trn even if its affinity for
dephosphorylated Trn is lower than that of the substrate-trap-
ping mutant for phosphorylated Trn.
Genetic interactions between Ptp52F and tartan. The results
described above show that Trn is a preferred substrate for
Ptp52F in S2 cells. It would be difficult to use biochemical
techniques to determine whether this is also the case in vivo,
because Trn is not an abundant protein, and it is unlikely to be
heavily tyrosine phosphorylated during normal development.
However, we can examine whether Ptp52F and Trn are in-
volved in the same developmental processes by using genetics.
Ptp52F, like other Drosophila RPTPs, is selectively ex-
pressed in CNS neurons and is a regulator of axon guidance.
When we identified the Ptp52F gene and isolated mutations in
it, we discovered that Ptp52F mutant embryos have two strong
axon guidance phenotypes. The longitudinal tracts in the CNS
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are disorganized and incomplete, and one branch of the motor
axon network, the SNa nerve, exhibits guidance errors (29).
During embryonic development, the 36 motor axons in each
abdominal hemisegment grow out from the CNS and segregate
into six major branches, called SNa, SNc, ISN, ISNb, ISNd, and
TN, which innervate the 30 body wall muscle fibers. Motor
axons can be selectively visualized by staining dissected em-
bryos with MAb 1D4 (34). Single mutations or combinations of
mutations in the six Rptp genes affect the guidance of all motor
axon branches (see reference 14 for a recent summary). Ptp52F
is the only Rptp gene for which single mutations affect the SNa
branch. In Ptp52F-null mutants, 40% of SNa nerves exhibit
guidance errors (Fig. 5F), while 22 to 27% have phenotypes in
hypomorphic (weaker) mutants. These are the only high-pen-
etrance motor axon phenotypes seen in Ptp52F single mutants.
There are also some ISN phenotypes (16%), but only rare
ISNb defects (7%) (29).
The SNa grows out from the CNS in the SN root and bifurcates
dorsal to muscle 12. Its posterior (or ventral) branch innervates
muscles 5 and 8, while its anterior (or dorsal) branch innervates
muscles 22 to 24 (Fig. 5A and E). The most common SNa guid-
ance error observed in Ptp52F mutants is a failure to bifurcate, so
FIG. 4. Phosphorylated Trn binds selectively to the Ptp52F substrate-trapping mutant in vitro. (A) Anti-PY immunoblot of a pervanadate-
treated S2 cell lysate incubated with the indicated amounts (in g) of Ptp52F-wild type-GST. (B) Anti-PY immunoblot of an anti-GFP IP from
a lysate of pervanadate-treated S2 cells transfected with the Trn-cyto-GFP plasmid. The bead-bound protein was incubated with the indicated
amounts (in g) of Ptp52F-wild type-GST (100-l reaction volume, 1 h, 20°C). The Trn-cyto-GFP band is indicated; other bands on the gel are
presumably background. Note that the PY signal for Trn-cyto-GFP was eliminated by 1 g of Ptp52F-wild type-GST (lane 2), showing that it
dephosphorylated Trn, but many bands in Fig. 4A (lane 2) were also diminished in intensity by this same amount of fusion protein. (C) Anti-PY
immunoblot of a GST “pulldown” experiment in which lysate from pervanadate-treated S2 cells transfected with the Trn-cyto-GFP plasmid was
incubated with the indicated amounts of Ptp52F-trap-GST (in g; 100-l volume), followed by precipitation of the trap-bound proteins with
glutathione-agarose beads. Only a single prominent band, of 85 kDa, was observed. The Trn-cyto-GFP band (60 kDa) was not detected.
(D) Anti-PY immunoblot of a GST pulldown experiment in which lysate from pervanadate-treated untransfected or Trn-FL-transfected S2 cells
was incubated with 10 g of Ptp52F-trap-GST or Ptp52F-wild type-GST, followed by precipitation of the bound proteins as in panel C. Note that
lysate from these cells produces a continuous smear but that only a single band is pulled down by Ptp52F-trap-GST, and the intensity of this band
is increased when Trn-FL is overexpressed. (E) An anti-Trn immunoblot of transfected cell pulldowns from the same experiment. The Trn band
is observed when either Ptp52F-trap-GST or Ptp52F-wild type-GST is used for pulldown, showing that wild-type Ptp52F dephosphorylates Trn but
can then remain bound to it.
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FIG. 5. Ptp52F and tartan mutants have the same motor axon guidance phenotypes, and the genes display a dosage-dependent interaction.
Motor axons (brown) in late-stage 16/early-stage 17 embryo “fillets” were stained with MAb 1D4, using HRP immunohistochemistry for
visualization, and photographed using differential interference contrast optics. (A) Two hemisegments in a wild-type (wt) control embryo. SNa, the
branch that exhibits phenotypes in both of these mutants, is labeled. Its bifurcation point is indicated by white arrows in both segments. The ISN
and ISNb (out of focus) are also labeled. Muscle fibers are labeled by number (compare to diagram of panel E). The anterior SNa branch normally
extends dorsally along muscle 22 and then across muscle 23 to reach muscle 24, and the posterior branch extends across muscle 5 to reach muscle
8. (B) Two hemisegments in a Ptp52F/, trn/ embryo (lacking one wild-type copy of each gene). The anterior branch of the SNa is missing in
both segments. The approximate points at which bifurcation would have occurred if the anterior branches were present are indicated by asterisks.
(C) Three hemisegments in a Ptp52F/Ptp52F embryo. The anterior branch of the SNa is missing, truncated, or misguided in all three. In the
left-hand hemisegment the branch is missing, while in the middle hemisegment axons branch off near the normal bifurcation point (asterisks) but
then grow posteriorly and rejoin the posterior SNa branch, forming a loop (arrowhead). In the right-hand hemisegment a thin and truncated
anterior branch is observed (arrowhead). (D) Two hemisegments in a trn/trn embryo. In the right-hand segment, the anterior branch is missing,
while in the left-hand hemisegment a single axon appears to have extended partway along the normal anterior branch pathway (arrowhead), leaving
the SNa near the normal bifurcation point (asterisks). (E) Diagram of the SNa and adjacent muscle fibers in wild-type. The muscles are indicated
as semitransparent to show their layering. The deepest (most external) muscles are 21 to 24, and they are overlaid by muscles 5, 12, 13, and 8. SNa
extends underneath (external to) 12 and 13. (F) Bar graph of phenotypic penetrance for SNa guidance errors, in control (balancer/); trn/;
Ptp52F/; Ptp52F/, trn/; trn/trn; and Ptp52F/Ptp52F cells. The numbers of hemisegments examined and the distribution among phenotypic
classes are shown in Table 2.
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that one branch is missing. The anterior branch is lost more
frequently than the posterior branch (Fig. 5C).
Trn is expressed in CNS neurons but also in a variety of
other cell types (3). Motor axon phenotypes had not been
previously analyzed in trn mutants. When we examined trn
mutant embryos by staining with MAb 1D4, we made the
remarkable discovery that they have SNa phenotypes that are
identical to those of Ptp52F mutants (Fig. 5D and F and Table
2). trn-null embryos display SNa defects with 40% pen-
etrance, and the most common phenotype is the absence of the
anterior branch. They also have ISNb defects, which are not
seen in Ptp52F mutants. Trn also has other functions in the
neuromuscular system; a recent paper from our group identi-
fied Trn and several other leucine-rich repeat proteins as syn-
aptic target selection cues on ventrolateral muscles. As part of
this analysis, we quantified ISNb and SNa phenotypes in trn-
null and trn-hypomorph embryos and also showed that these
phenotypes are primarily due to loss of Trn from neurons (22).
In the present study, our major purpose is to document the
shared Ptp52F and trn SNa guidance phenotype and to deter-
mine whether the two proteins function within the same path-
way or process. To do this, we examined dosage-sensitive ge-
netic interactions between them. This is a standard method for
establishing whether two gene products are functionally re-
lated. An example that is relevant to axon guidance is provided
by the Roundabout (Robo) receptor and its ligand Slit; re-
moval of 50% of gene function for both Slit and Robo (in
slit/, robo/ embryos) pathway components produces defects
that could otherwise only be generated by complete loss of
Robo (20).
We analyzed Ptp52F and Trn in a similar manner and found
that Ptp52F/ and trn/ embryos do not display SNa guidance
errors (null mutations were used for both genes). However,
Ptp52F/, trn/ embryos have SNa phenotypes like those seen
in Ptp52F/Ptp52F or trn/trn embryos, with a penetrance of 27%
(Fig. 5B and F and Table 2). The differences in penetrance
between Ptp52F/, trn/ embryos and Ptp52F/ or trn/ em-
bryos are statistically significant (P  0.0001, chi-square test).
Ptp52F/, trn/ embryos do not have CNS or ISNb pheno-
types. These phenotypes are not shared between Ptp52F/
Ptp52F and trn/trn and therefore presumably involve pathways
that do not require both proteins. In summary, our results
suggest that bifurcation of the SNa nerve is dependent on a
pathway that includes both Ptp52F and Trn.
Another way to evaluate genetic interactions is through sup-
pression of a gain-of-function phenotype for one gene by a loss
of function for the other. Neuronal overexpression of Trn did
not produce phenotypes, so the potential role of Ptp52F in
altering Trn signaling through dephosphorylation could not be
examined in this manner. Neuronal overexpression of Ptp52F,
however, generates CNS axon guidance phenotypes (26), and
these are suppressed by removal of trn function (see Fig. S1 in
the supplemental material). This represents a requirement for
Trn in mediating Ptp52F function, rather than control of Trn
by Ptp52F. Perhaps the normal activity of Ptp52F in vivo re-
quires formation of a complex with Trn.
DISCUSSION
In this study, we present evidence that the cell surface re-
ceptor Trn is a substrate for Ptp52F. Trn was identified in a
yeast screen for phosphoproteins that bind selectively to a
Ptp52F substrate-trapping mutant (Table 1 and Fig. 1). We
showed that Trn can be phosphorylated on tyrosine in S2 cells
(Fig. 2) and that phosphorylated Trn binds selectively to the
substrate-trapping mutant of Ptp52F when it is coexpressed
with Trn and the v-Src kinase (Fig. 3B, E, and F). Wild-type
Ptp52F causes dephosphorylation of v-Src-phosphorylated Trn
in S2 cells (Fig. 3D). A purified Ptp52F–wild-type–GST fusion
protein can dephosphorylate Trn in a pervanadate-treated S2
cell lysate, but it also dephosphorylates many other proteins in
the lysate. However, a Ptp52F-trap-GST fusion protein binds
to only one phosphoprotein in pervanadate-treated S2 lysates,
and we identified this protein as Trn (Fig. 4C to E). Ptp52F-
wild type-GST forms a complex with Trn that persists after
dephosphorylation (Fig. 4D and E). These data demonstrate
that the Ptp52F substrate-trapping mutant has a strong speci-
ficity for Trn binding. Our results fulfill all three of the criteria
listed by Tiganis and Bennett (32) as necessary for the rigorous
definition of a protein as a PTP substrate: (i) direct interaction
with the PTP substrate-trapping mutant in transfected cells,
(ii) modulation of cellular substrate tyrosine phosphorylation
by the PTP in transfected cells, and (iii) in vitro dephosphor-
ylation of substrate by the PTP.
Our genetic results (Fig. 5) are consistent with a model in
which Trn signaling in SNa motor neurons is necessary for
correct axon pathfinding at the SNa bifurcation point, and
Ptp52F regulates Trn via dephosphorylation. In trn and Ptp52F
mutants, SNa axons destined for muscles 22 to 24 sometimes
fail to separate from those destined for muscles 5 and 8. This
results in a phenotype in which the anterior branch of the SNa
is missing. In SNa growth cones, signaling through Trn and
dephosphorylation of Trn by Ptp52F might be regulated by the
interactions of these two receptors with unknown ligands on
cells near the SNa bifurcation point. Activation of Ptp52F
might involve a secreted protein called Folded gastrulation
(Fog), which is expressed in this vicinity. Fog is a positive
regulator of Ptp52F function in SNa neurons (26).
Trn is also important for ISNb axon guidance (22) and is
involved in many other developmental processes, including
tracheal development and the sorting of cells within imaginal
discs and developing appendages (21, 23, 24, 28). Trn signaling
in ISNb neurons and tracheae may be independent of Ptp52F,
since trn and Ptp52F do not share ISNb or tracheal phenotypes.
How does Ptp52F regulate Trn signaling in neurons? One
might have expected that Ptp52F would be a negative regulator
of Trn, because dephosphorylation of Trn would prevent it
TABLE 2. Quantitation of SNa phenotypes
Genotype
No. of
hemisegments
(A2 to A6)
scored
Phenotypic percentage
Missing
branches
Extra
branches Bypass Total
balancer/ (control) 339 5 1 0 6
trn/ 178 4 2 0 6
Ptp52F/ 131 3 0 0 3
Ptp52F/, trn/ 198 26 1 0 27
trn/trn 192 30 12 2 44
Ptp52F/Ptp52F 169 42 4 2 48
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from binding to SH2-domain downstream signaling proteins.
Several Y residues in the Trn cytoplasmic domain are in se-
quence contexts that suggest that they could bind to SH2 do-
mains if they were phosphorylated. In this model, however,
mutation of Ptp52F should lead to an increase rather than a
decrease in Trn signaling. We do not know what consequences
might result from increasing Trn signaling, since overexpres-
sion of Trn in neurons does not produce phenotypes (data not
shown). However, the fact that the trn and Ptp52F loss-of-
function phenotypes are the same and that the two genes
interact in a dosage-dependent manner suggests that Trn sig-
naling is reduced in the absence of Ptp52F and thus that
Ptp52F is actually a positive regulator of Trn.
Interestingly, these relationships between the Trn receptor,
the unknown TK that phosphorylates Trn in vivo, and the
RPTP resemble those described for the Robo receptor, which
controls axon guidance across the CNS midline. Robo signal-
ing is antagonized by the Abl TK (1), which can phosphorylate
its cytoplasmic domain, and is facilitated by the Ptp10D and
Ptp69D RPTPs (30). There are several models that could ex-
plain this apparent positive regulation by dephosphorylation.
Tyrosine-phosphorylated Trn or Robo might be downregu-
lated by endocytosis. It is known that Robo can be regulated in
this manner: the transmembrane protein Commissureless,
which downregulates Robo function in vivo, can remove it
from the cell surface by diverting it into an endocytic pathway
(12, 19). In another model, an SH2-domain protein might bind
to a phosphorylated tyrosine residue in Trn or Robo and oc-
clude binding of a positive regulator that normally binds to an
adjacent site in a phosphorylation-independent manner.
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